Similar articles

• Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.

  Chalasani N, Li YJ, Dellinger A, Navarro V, Bonkovsky H, Fontana RJ, Gu J, Barnhart H, Phillips E, Lammert C, Schwantes-An TH, Nicoletti P, Kleiner DE, Hoofnagle JH; Drug Induced Liver Injury Network. Chalasani N, et al. J Hepatol. 2023 Feb;78(2):293-300. doi: 10.1016/j.jhep.2022.09.010. Epub 2022 Sep 22. J Hepatol. 2023. PMID: 36152763 Free PMC article.
• [Autoimmune hepatitis triggered by nitrofurantoin: A rare drug-induced toxicity].

  Sorin B, Pineton de Chambrun M, Haroche J, Freund Y, Miyara M, Charlotte F, Lebrun-Vignes B, Amoura Z, Cohen Aubart F. Sorin B, et al. Rev Med Interne. 2016 Feb;37(2):131-4. doi: 10.1016/j.revmed.2015.07.003. Epub 2015 Sep 26. Rev Med Interne. 2016. PMID: 26404522 French.
• [Acute hepatitis and pneumonitis associated with nitrofurantoin].

  Kursbaum A, Rottenstreich E. Kursbaum A, et al. Harefuah. 1990 Dec 16;119(12):427-8. Harefuah. 1990. PMID: 2074065 Hebrew.
• Drug-induced autoimmune-like hepatitis.

  Czaja AJ. Czaja AJ. Dig Dis Sci. 2011 Apr;56(4):958-76. doi: 10.1007/s10620-011-1611-4. Epub 2011 Feb 16. Dig Dis Sci. 2011. PMID: 21327704 Review.
• Aging liver and hepatitis.

  Junaidi O, Di Bisceglie AM. Junaidi O, et al. Clin Geriatr Med. 2007 Nov;23(4):889-903, viii. doi: 10.1016/j.cger.2007.06.006. Clin Geriatr Med. 2007. PMID: 17923344 Review.